uracil has been researched along with Herpes Zoster in 3 studies
2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder
Herpes Zoster: An acute infectious, usually self-limited, disease believed to represent activation of latent varicella-zoster virus (HERPESVIRUS 3, HUMAN) in those who have been rendered partially immune after a previous attack of CHICKENPOX. It involves the SENSORY GANGLIA and their areas of innervation and is characterized by severe neuralgic pain along the distribution of the affected nerve and crops of clustered vesicles over the area. (From Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sorivudine was given orally as 40 mg once-daily doses for 10 consecutive days to a total of 19 patients with herpes zoster." | 9.08 | The effect of sorivudine on dihydropyrimidine dehydrogenase activity in patients with acute herpes zoster. ( Diasio, RB; Haworth, S; Lee, PC; McCrary, MM; Olsen, SJ; Raymond, R; Tyring, SK; Yan, J, 1997) |
| "Sorivudine was given orally as 40 mg once-daily doses for 10 consecutive days to a total of 19 patients with herpes zoster." | 5.08 | The effect of sorivudine on dihydropyrimidine dehydrogenase activity in patients with acute herpes zoster. ( Diasio, RB; Haworth, S; Lee, PC; McCrary, MM; Olsen, SJ; Raymond, R; Tyring, SK; Yan, J, 1997) |
| "The alphaherpesvirus varicella-zoster virus (VZV) causes chickenpox and shingles." | 1.40 | β-l-1-[5-(E-2-bromovinyl)-2-(hydroxymethyl)-1,3-(dioxolan-4-yl)] uracil (l-BHDU) prevents varicella-zoster virus replication in a SCID-Hu mouse model and does not interfere with 5-fluorouracil catabolism. ( Arnold, RD; Chavre, S; Chu, CK; De, C; Hagen, FK; Liu, D; Moffat, JF; Singh, US; White, C; Zheng, B, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De, C | 1 |
| Liu, D | 1 |
| Zheng, B | 1 |
| Singh, US | 1 |
| Chavre, S | 1 |
| White, C | 1 |
| Arnold, RD | 1 |
| Hagen, FK | 1 |
| Chu, CK | 1 |
| Moffat, JF | 1 |
| KOCH, P | 1 |
| Yan, J | 1 |
| Tyring, SK | 1 |
| McCrary, MM | 1 |
| Lee, PC | 1 |
| Haworth, S | 1 |
| Raymond, R | 1 |
| Olsen, SJ | 1 |
| Diasio, RB | 1 |
1 trial available for uracil and Herpes Zoster
| Article | Year |
|---|---|
The effect of sorivudine on dihydropyrimidine dehydrogenase activity in patients with acute herpes zoster.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Analysis of Variance; Antiviral Agents; Arab | 1997 |
2 other studies available for uracil and Herpes Zoster
| Article | Year |
|---|---|
β-l-1-[5-(E-2-bromovinyl)-2-(hydroxymethyl)-1,3-(dioxolan-4-yl)] uracil (l-BHDU) prevents varicella-zoster virus replication in a SCID-Hu mouse model and does not interfere with 5-fluorouracil catabolism.
Topics: Acyclovir; Animals; Antiviral Agents; Bromodeoxyuridine; Cell Line; Chickenpox; Dioxolanes; Drug The | 2014 |
[EXPERIENCES WITH THE VIROSTATIC IODOURACIL DESOXYRIBOSIDE (IUDR) IN HERPES DISEASES OF THE EYE].
Topics: Drug Therapy; Eye; Herpes Zoster; Herpes Zoster Ophthalmicus; Humans; Idoxuridine; Keratitis; Kerati | 1965 |